| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | United States | 3 | |
| #4 | China | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology | |
| #4 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Diagnosis and surgery | |
| #5 | Peptides | |
| #6 | Fermentation | |
| #7 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Meikle Peter John | 7 |
| #2 | Haviv Izhak | 7 |
| #3 | Bedo Justin | 7 |
| #4 | Goudey Benjamin | 7 |
| #5 | Kingwell Bronwyn Anne | 6 |
| #6 | Choy Mei Yee | 2 |
| #7 | Hagemeyer Christoph Eugen | 2 |
| #8 | Shaw Jonathan | 1 |
| #9 | Johnston Angus Philip Rayner | 1 |
| #10 | Peter Karlheinz | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN109922817A | The agent and method of relevant disease are had enough to meet the need to extracellular matrix for diagnosing and treating | |
| WO2016041013A1 | Glycerolipids and uses therefor | |
| EP2836128A1 | Atherosclerotic plaque detection | |
| WO2012142659A1 | Site-selective modification of proteins | |
| WO2012122602A1 | Lipidomic method for assessing diabetes, pre-diabetes and obesity | |
| EP2504708A1 | Lipid biomarkers for stable and unstable heart disease |